Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

“Rehab for all!” Is it too early in pulmonary arterial hypertension?

Laurent Bertoletti, Hélène Bouvaist, Cécile Tromeur, Souad Bezzeghoud, Claire Dauphin, Irina Enache, Arnaud Bourdin, Marie-France Seronde, David Montani, Ségolène Turquier, Christophe Pison on behalf of the FONCE-HTAP investigators
European Respiratory Journal 2019 54: 1901558; DOI: 10.1183/13993003.01558-2019
Laurent Bertoletti
1Service de Médecine Vasculaire et Thérapeutique, CHU de St-Etienne, Saint-Etienne, France
2INSERM, UMR1059, Equipe Dysfonction Vasculaire et Hémostase, Université Jean-Monnet, Saint-Etienne, France
3INSERM, CIC-1408, CHU Saint-Etienne, Saint-Etienne, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Laurent Bertoletti
  • For correspondence: laurent.bertoletti@gmail.com
Hélène Bouvaist
4Service de cardiologie, CHU de Grenoble, Grenoble, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cécile Tromeur
5Département de médecine vasculaire, interne et pneumologie, EA 3878 (GETBO), Hôpital de la Cavale Blanche, CHRU de Brest, Brest, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Souad Bezzeghoud
1Service de Médecine Vasculaire et Thérapeutique, CHU de St-Etienne, Saint-Etienne, France
3INSERM, CIC-1408, CHU Saint-Etienne, Saint-Etienne, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claire Dauphin
6Service de cardiologie, CHU de Clermont-Ferrand, Clermont-Ferrand, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irina Enache
7Service de Physiologie, CHU de Strasbourg, Strasbourg, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arnaud Bourdin
8Service de Pneumologie, CHU de Montpellier, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie-France Seronde
9Service de Cardiologie, CHU de Besançon, Besançon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Montani
10Service de Pneumologie, Hôpital du Kremlin Bicêtre, AP-HP, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David Montani
Ségolène Turquier
11Service de physiologie, Hospices Civils de Lyon, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christophe Pison
12Service de Pneumologie, CHU de Grenoble, Grenoble, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Extract

Chronic pulmonary hypertension shares abnormalities found in chronic left heart failure and chronic respiratory failure, in which rehabilitation has been proposed [1, 2]. In a recent statement endorsed by the European Respiratory Society, Grünig et al. [3] proposed an exhaustive review of available data on rehabilitation in the setting of chronic pulmonary hypertension. The main messages proposed are “Specialised exercise training in patients with pulmonary hypertension appears to be effective, cost-efficient and safe.”

Abstract

Rehabilitation appears to be beneficial in PAH patients, but more research is needed before increasing the level of evidence for recommendations. http://bit.ly/33zutuZ

Acknowledgements

The authors thank Deirdre Epinat (Laniel Traduction SA, Saint-Etienne, 42000, France) for English editing.

Footnotes

  • The FONCE-HTAP investigators are as follows. Steering committee: Laurent Bertoletti (Chairman), Hélène Bouvaist, Bruno Degano, Christophe Pison. Coordination centre: Laurent Bertoletti, Souad Bezzeghoud, Carine Labruyere. Investigators: Saint-Etienne: Laurent Bertoletti (PI), Stéphanie Chomette Ballereau, Sandrine Accassat, Elodie De Magalhaes, David Hupin, Pierre Labeix, Pierre Croisille. Grenoble: Christophe Pison (PI), Hélène Bouvaist, Bruno Degano, Marianne Noirclerc. Clermont-Ferrand: Claire Dauphin (PI), Romain Tresorier, Fréderic Costes. Brest: Cécile Tromeur (PI), Francis Couturaud, Christophe Gut-Gobert. Lyon: Ségolène Turquier (PI), Vincent Cottin, Julie Traclet, Sophie Lamoureux, Clément Deudon.Strasbourg: Irina Enache (PI), Marianne Riou, Mathieu Canuet, Armelle Schuller, Evelyne Lonsdorfer. Besançon: Marie-France Seronde (PI), Pauline Marie Roux. Montpellier: Arnaud Bourdin (PI), Clément Boissin, Anne-Sophie Gamez-Dubuis. Paris: David Montani (PI), Gilles Garcia, Pierantonio Laveneziana, Antoine Guerder, Marc Humbert.

  • Conflict of interest: L. Bertoletti has nothing to disclose.

  • Conflict of interest: H. Bouvaist reports grants and non-financial support from GSK and MSD, and personal fees and non-financial support from Actelion, outside the submitted work.

  • Conflict of interest: C. Tromeur has nothing to disclose.

  • Conflict of interest: S. Bezzeghoud has nothing to disclose.

  • Conflict of interest: C. Dauphin has nothing to disclose.

  • Conflict of interest: I. Enache has nothing to disclose.

  • Conflict of interest: A. Bourdin reports grants, personal fees, non-financial support and other from AstraZeneca, GSK and Boehringer Ingelheim, personal fees and other from Chiesi, personal fees, non-financial support and other from Novartis, Actelion and Sanofi Regeneron, and other funding from United Therapeutics, Vertex, Galapagos, Biogen and BTG, outside the submitted work.

  • Conflict of interest: M-F. Seronde has nothing to disclose.

  • Conflict of interest: D. Montani reports grants and personal fees from Actelion and Bayer, and personal fees from GSK, MSD and Pfizer, outside the submitted work.

  • Conflict of interest: S. Turquier has nothing to disclose.

  • Conflict of interest: C. Pison has nothing to disclose.

  • Support statement: Support was received from the Ministère des Affaires Sociales et de la Santé, grant PHRCi 2013, and AIRE (AIde à la REcherche médicale de proximité; https://aire-loire.fr/). Funding information for this article has been deposited with the Crossref Funder Registry.

  • Received August 5, 2019.
  • Accepted August 7, 2019.
  • Copyright ©ERS 2019
https://www.ersjournals.com/user-licence
View Full Text

ERS Members

myERS - ERS members : log in with your myERS username and password.

INDIVIDUALS

Log in Login as an individual user.

Forgot your username or password?

LIBRARY USERS

Log in through your institution

If your library has a subscription, you may already be logged in via your IP address. Otherwise you may be able to log in via one of the following routes.
You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.
If you think you should have access, please contact your librarian or email journals@ersnet.org

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top
View this article with LENS
Vol 54 Issue 5 Table of Contents
European Respiratory Journal: 54 (5)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
“Rehab for all!” Is it too early in pulmonary arterial hypertension?
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
“Rehab for all!” Is it too early in pulmonary arterial hypertension?
Laurent Bertoletti, Hélène Bouvaist, Cécile Tromeur, Souad Bezzeghoud, Claire Dauphin, Irina Enache, Arnaud Bourdin, Marie-France Seronde, David Montani, Ségolène Turquier, Christophe Pison
European Respiratory Journal Nov 2019, 54 (5) 1901558; DOI: 10.1183/13993003.01558-2019

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
“Rehab for all!” Is it too early in pulmonary arterial hypertension?
Laurent Bertoletti, Hélène Bouvaist, Cécile Tromeur, Souad Bezzeghoud, Claire Dauphin, Irina Enache, Arnaud Bourdin, Marie-France Seronde, David Montani, Ségolène Turquier, Christophe Pison
European Respiratory Journal Nov 2019, 54 (5) 1901558; DOI: 10.1183/13993003.01558-2019
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Shareable PDF
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Efficacy of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis
  • Ethical obligations for supporting healthcare workers during the COVID-19 pandemic
  • Reversible pulmonary hypertension with multivisceral Whipple's disease
Show more Agora

Correspondence

  • Efficacy of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis
  • Ethical obligations for supporting healthcare workers during the COVID-19 pandemic
  • Reversible pulmonary hypertension with multivisceral Whipple's disease
Show more Correspondence

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society